Back to search

Article

Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin to treat hepatocellular carcinoma

2023-12-29

Abstract excerpt

<h4>Background: </h4> Galangin, a flavonoid compound, is derived from Alpinia officinarum Hance. Previous studies have shown that galangin can inhibit the proliferation of hepatocellular carcinoma (HCC), but its mechanism is still unclear. This study aims to investigate the potential targets and molecular mechanisms of galangin on HCC through network pharmacology, bioinformatics, molecular docking, and experimenta...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
27526e26-6d3c-504c-9b2d-f90ee18d24ec
DOI
10.21203/rs.3.rs-3769897/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin to treat hepatocellular carcinomaDOI 10.21203/rs.3.rs-3769897/v1
Select a neighboring publication to make it the new centre.